Differentiating high-grade cervical intraepithelial lesion from atrophy in postmenopausal women using Ki-67, cyclin E, and p16 immunohistochemical analysis

Journal of Lower Genital Tract Disease

Volumn 9, Issue 2, 2005, Pages 100-107

  Qiao, Xiaoying ^a,c   Bhuiya, Tawfiqul A ^a   Spitzer, Mark ^b  

^a LONG ISLAND JEWISH MEDICAL CENTER   (United States)

^b NEW YORK METHODIST HOSPITAL   (United States)

^c LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Cyclin E; High grade cervical intraepithelial neoplasia; Ki 67; p16; Postmenopausal atrophy

Indexed keywords

AVIDIN; BIOTIN; CYCLIN E; EOSIN; FORMALDEHYDE; HEMATOXYLIN; KI 67 ANTIGEN; MONOCLONAL ANTIBODY; PARAFFIN; PEROXIDASE; PROTEIN P16;

ADULT; AGED; ARTICLE; ATROPHY; BIOPSY; CANCER GRADING; COMPARATIVE STUDY; EPITHELIUM; FEMALE; HUMAN; HUMAN TISSUE; HYSTERECTOMY; IMMUNOHISTOCHEMISTRY; LASER; MAJOR CLINICAL STUDY; POSTMENOPAUSE; STAINING; UTERINE CERVIX CARCINOMA IN SITU;

AGED; AGED, 80 AND OVER; ATROPHY; CERVICAL INTRAEPITHELIAL NEOPLASIA; CYCLIN E; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MIDDLE AGED; POSTMENOPAUSE; TUMOR MARKERS, BIOLOGICAL; UTERINE CERVICAL NEOPLASMS;

EID: 16244415576     PISSN: 10892591     EISSN: None     Source Type: Journal    
DOI: 10.1097/00128360-200504000-00006     Document Type: Article

References (17)

1. Kurman, RJ, Norris, HJ, Wilkinson, E. Tumor of the cervix. In: AFIP: Tumor of the Cervix, Vagina, and Vulva. 3rd ed. Bethesda, MD: Universities Association for Research and Education in Pathology, Inc.; 1990:37-55.
2. Abati A, Jaffurs W, Wilder AM. Squamous atypia in the atrophic cervical vaginal smear: a new look at an old problem. Cancer 1998;84:218-25.
3. Solomon D, Davey D, Kurman R, Moriarty A, O'Connor D, Prey M, et al. The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA 2002;287:2114-9.
4. Keating JT, Cviko A, Riethdorf S, Riethdorf L, Quade BJ, Sun D, et al. Ki-67, cyclin E, and p16INK4 are complimentary surrogate biomarkers for human papillomavirus-related cervical neoplasia. Am J Surg Pathol 2001;25:884-91.
5. Pirog EC, Baergen RN, Soslow RA, Tam D, Demattia AE, Chen YT, et al. Diagnostic accuracy of cervical low-grade intraepithelial lesions is improved with MIB-1 immunostaining. Am J Surg Pathol 2002;26:70-5.
6. Ki-67 primary antibody. Ventana. Catalog 250-2520.
7. Pirog EC, Chen YT, Isacson C. MIB-1 immunostaining is a beneficial adjunct test for the accurate diagnosis of vulvar condyloma acuminatum. Am J Surg Pathol 2000;24:1393-9.
8. Cotran RS, Kumar V, Collins T, eds. Neoplasia. In: Robbins Pathologic Basis of Disease. 6th ed. Philadelphia: WB Saunders; 1999:260-327.
9. Lees E, Faha B, Dulic V, Reed SI, Harlow E. Cyclin E/cdk2 and cyclin A/cdk2 kinases associate with p107 and E2F in a temporally distinct manner. Genes Dev 1992;6:1874-85.
10. Quade BJ, Park JJ, Crum CP, Sun D, Dutta A. in vivo cyclin E expression as a marker for early cervical neoplasia. Mod Pathol 1998;11:1238-46.
11. Ortega S, Malumbres M, Barbacid M. Cyclin D-dependent kinase, INK4 inhibitors and cancer. Biochim Biophys Acta 2002;1602:73-87.
12. Sano T, Masuda N, Oyama T, Nakajima T. Overexpression of p16 and p14ARF is associated with human papillomavirus infection in cervical squamous cell carcinoma and dysplasia. Pathol Int 2002;52:375-83.
13. Klaes R, Benner A, Friedrich T, Ridder R, Herrington S, Jenkins D, et al. P16INK4a immunohistochemistry improves interobserver agreement in the diagnosis of cervical intraepithelial neoplasia. Am J Surg Pathol 2002;26:1389-99.
14. Klaes R, Friedrich T, Spitrovsky D, Rider R, Rudy W, Petry U, et al. Overexpression of p16INK4a as a specific marker for dysplastic and neoplastic epithelial cells of the cervical uteri. Int J Cancer 2001;92:276-84.
15. Malanchi I, Caldeira S, Krutzfeldt M, Giarre M, Alunni-Fabbroni M. Identification of a novel activity of human papillomavirus type 16 E6 protein in deregulation the G1/S transition. Oncogene 2002;21:5665-72.
16. Caldeira S, Dong W, Tomakidi P, Paradiso A, Tommasino M. Human papillomavirus type 32 does not display in vitro transforming properties. Virology 2002;301:157-64.
17. Lu DW, Pirog EC, Zhu X, Wang HL, Pinto KR. Prevalence and typing of HPV DNA in atypical squamous cells in pregnant women. Acta Cytol 2003;47:1008-16.